Navigation Links
Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18

intramuscular injection. No adverse effects on mating, fertility, pregnancy, parturition, lactation, embryo-fetal or pre- and postweaning development were observed. There were no vaccine-related fetal malformations or other evidence of teratogenesis noted in this study. In addition, there were no treatment-related effects on developmental signs, behavior, reproductive performance, or fertility of the offspring. The effect of GARDASIL on male fertility has not been studied. In clinical studies, women underwent urine pregnancy testing prior to administration of each dose of GARDASIL. Women who were found to be pregnant before completion of a 3-dose regimen of GARDASIL were instructed to defer completion of their vaccination regimen until resolution of the pregnancy. During clinical trials, 2266 women (vaccine = 1115 vs. placebo = 1151) reported at least 1 pregnancy each. Overall, the proportions of pregnancies with an adverse outcome were comparable in subjects who received GARDASIL and subjects who received placebo. Overall, 40 and 41 subjects in the group that received GARDASIL or placebo, respectively (3.6% and 3.6% of all subjects who reported a pregnancy in the respective vaccination groups), experienced a serious adverse experience during pregnancy. The most common events reported were conditions that can result in Caesarean section (e.g., failure of labor, malpresentation, cephalopelvic disproportion), premature onset of labor (e.g., threatened abortions, premature rupture of membranes), and pregnancy-related medical problems (e.g., pre-eclampsia, hyperemesis). The proportions of pregnant subjects who experienced such events were comparable between the vaccination groups. There were 15 cases of congenital anomaly in pregnancies that occurred in subjects who received GARDASIL and 16 cases of congenital anomaly in pregnancies that occurred in subjects who received placebo. Further sub-analyses were conducted to evalua
'"/>




Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32

Related medicine technology :

1. New Phase 3 Study Published in The Lancet Evaluates Efficacy and Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination Therapy in Treatment-Experienced Adults With HIV
2. New Proof of Genisteins Efficacy and Safety for Osteopenia and Osteoporosis Published in Annals of Internal Medicine
3. Bio-Matrix Scientifics Dr. ONeill Sees University of Pittsburghs Published Study on Culture Blood-Forming Stem Cells from Human Fat Tissue as Supporting Near Term Benefits of Banking Adipose (Fat) Derived Stem Cells
4. Interim Analysis of Crinone Pregnancy Study to Be Published in American Society for Reproductive Medicine Journal
5. VIVUS Announces Abstract Published at American Diabetes Association Scientific Sessions
6. Anacor Identifies a Novel Mechanism for Its Lead Anti-Fungal Drug, AN2690; Findings Published in Science
7. Research on New Treatment for Neglected Disease Published in The New England Journal of Medicine
8. Landmark Study Published in the New England Journal of Medicine Shows Important Benefits of Eprodisate (KIACTA) Treatment for Patients with Amyloid A (AA) Amyloidosis
9. Newly Published Data from Large Study Support Cardiovascular Safety of Avandia (Rosiglitazone Maleate)
10. Javelin Pharmaceuticals Phase II Rylomine (Intranasal Morphine) Data Published in Pain Medicine
11. Newly Published Data Demonstrates Superiority of Cipralex Over Duloxetine for Acute Treatment of Depression
Post Your Comments:
(Date:7/7/2015)... -- Dedicated to promoting wellness and giving back to its ... purple pledge in support of Alzheimer,s & Brain-Awareness Month. ... time to shine a purple light for the millions ... in our community who are affected by Alzheimer,s. Raising ... helps mobilize friends, family members, neighbors and coworkers to ...
(Date:7/7/2015)... -- The Global Breast Pumps Market ... at an estimated CAGR of 7.6% from 2014 to 2020, ... Introduction of innovative technologies including hand free breast pumps, growing ... the advantages of breast milk are expected to drive breast ... of untapped growth opportunities in emerging markets such as ...
(Date:7/7/2015)... , July 7, 2015  Essentialis, a venture-backed company focused ... the treatment of orphan neurobehavioral and metabolic diseases, today announced ... will present a corporate update at the Cantor Fitzgerald Inaugural ... Date: Wednesday, July 8, 2015 Time: 8:00 AM ... About Essentialis, Inc. Essentialis is ...
Breaking Medicine Technology:Purple for a Purpose: Supporting Alzheimer's & Brain-Awareness Month 2Breast Pumps Market To Reach $1,197.7 Million By 2020: Grand View Research, Inc. 2Breast Pumps Market To Reach $1,197.7 Million By 2020: Grand View Research, Inc. 3Breast Pumps Market To Reach $1,197.7 Million By 2020: Grand View Research, Inc. 4
... 10, 2011 The American Society of Bariatric Physicians (ASBP) ...  Our condolences go out to his family, friends and fans. ... phentermine was a contributing factor to his death are concerning ... medications as prescribed. While the specific details ...
... Sciences International, Inc. (Nasdaq: BDSI ) ... study of a formulation of buprenorphine and naloxone ... technology.   (Logo: http://photos.prnewswire.com/prnh/20110217/CL49801LOGO ) ... to select the final doses of BEMA Buprenorphine/Naloxone ...
Cached Medicine Technology:Physicians Who Treat Obesity Respond to the News of Bubba Smith's Overdose 2BioDelivery Sciences Initiates Confirmatory Pharmacokinetic Study of BEMA Buprenorphine/Naloxone Compared to Suboxone 2BioDelivery Sciences Initiates Confirmatory Pharmacokinetic Study of BEMA Buprenorphine/Naloxone Compared to Suboxone 3BioDelivery Sciences Initiates Confirmatory Pharmacokinetic Study of BEMA Buprenorphine/Naloxone Compared to Suboxone 4
(Date:7/7/2015)... ... July 07, 2015 , ... ... at the Aspen Ideas Festival (AIF), identifying 18 possible melanomas and 46 potential ... be confirmed with additional testing. , The Aspen Ideas Festival, which was held ...
(Date:7/7/2015)... (PRWEB) , ... July 07, ... ... Francisco-based Hope Consulting announced today that the two firms have merged to ... the social, health and biopharma sectors. The merger combines SwitchPoint’s strategy consulting ...
(Date:7/7/2015)... ... July 07, 2015 , ... Illinois ... board is limited to permit holders. The Medical Cannabis Alliance of Illinois’ (MCAI) ... industry forward and are committed to making sure patients have access to cannabis ...
(Date:7/7/2015)... LINCOLN, R.I. (PRWEB) , ... July 07, 2015 , ... ... take the proper precautions, however, so Amica Insurance is sharing some safety tips. , ... activities, sports and gardening: , Leisure activities/sports, , Start slowly. ...
(Date:7/7/2015)... (PRWEB) , ... July 07, 2015 , ... ... heart of Downtown Detroit was the site of the National Baptist Convention 110th ... Initiative. Focusing on encouraging and promoting the collaboration of churches and their congregations, ...
Breaking Medicine News(10 mins):Health News:More than 700 Screened for Skin Cancer at 2015 Aspen Ideas Festival 2Health News:More than 700 Screened for Skin Cancer at 2015 Aspen Ideas Festival 3Health News:More than 700 Screened for Skin Cancer at 2015 Aspen Ideas Festival 4Health News:SwitchPoint and Hope Consulting Have Merged to Form Camber Collective 2Health News:Cannabis Growers and Dispensaries Form Medical Cannabis Alliance of Illinois 2Health News:Amica Insurance Has 7 Summer Safety Tips 2Health News:A Forever Recovery CEO Per Wickstrom Speaks to Audience at National Baptist Convention's 11th Annual Health Fair 2Health News:A Forever Recovery CEO Per Wickstrom Speaks to Audience at National Baptist Convention's 11th Annual Health Fair 3
... us can recall having difficulty deciphering health information at ... a// prescription too soon because you didn’t understand the ... reading the label on the bottle, low health literacy ... ,Communication problems with health professionals can negatively ...
... who are deprived of company and sad and lonely at the ... stress hormone cortisol in their blood the next morning,// researchers reported ... USA. ,Hormone cortisol is released in the body ... levels also vary through out the day. ,In ...
... states has been infected by a salmonella outbreak according to ... assumed to have spread through some form of produce including ... specific product, chain, restaurants or supermarkets as yet. ... by a common form of salmonella bacteria. Health officials state ...
... Durex best-selling 'extra safe' range were seized in west London ... the company could not 'guarantee the safety' of the fakes. ... UK was also unknown,These counterfeits came to light only after ... the company's laboratories it was confirmed that these were fakes. ...
... have developed a light-emitting sticking plaster, which they claim ... successfully. This// user-friendly device, which can be used by ... light source that is powered by a pocket-sized battery. ... Professor James Ferguson took 4 years to create this ...
... Turmeric the must have spice in every Indian home now ... its potential uses to fight// many tubborn inflammations and degenerative ... the ancient scripts of Ayurveda. ,According to a ... Medicine by Janet L. Funk, MD, working with Barbara N. ...
Cached Medicine News:Health News:Low Health Literacy Interferes with Good Health Care 2Health News:Salmonella Outbreak under Investigation 2Health News:Innovative treatment for Skin Cancer 2
The 920M PLUS handheld pulseoximeter provides on-the-spot bloodoximetry and heart rate readings....
Rad-5 signal extraction pulse oximeter™...
... 3100 is a small, lightweight ... worn comfortably on the patients ... activities and for overnight studies, ... WristOx is intended to give ...
The pocket-size Invacare Digit finger pulse oximeter is a convenient and economical solution to fast, reliable SpO2, pulse rate and pulse strength measurements. Its compact size is ideal for home use...
Medicine Products: